Circulating soluble intercellular adhesion molecule-1 (sICAM-1) in active inflammatory bowel disease

Area of Science:

• Immunology
• Gastroenterology
• Biochemistry

Background:

• Intercellular adhesion molecule-1 (ICAM-1) is crucial for immune cell interactions.
• Soluble ICAM-1 (sICAM-1) is a marker of cellular immune responses.
• Inflammatory bowel disease (IBD) involves chronic immune system dysregulation.

Purpose of the Study:

• To investigate serum levels of sICAM-1 in patients with ulcerative colitis (UC) and Crohn's disease (CD).
• To compare sICAM-1 levels between active and inactive disease states, and with healthy controls.
• To explore correlations between sICAM-1 and other inflammatory markers.

Main Methods:

• Serum sICAM-1 concentrations were quantified using enzyme-linked immunosorbent assay (ELISA).
• Study included 27 UC patients, 31 CD patients, and 29 healthy controls.
• Statistical analyses included median comparisons, variance analysis for trend, and correlation analysis.

Main Results:

• IBD patients exhibited significantly higher median sICAM-1 levels (355 ng/ml) compared to controls (245 ng/ml) (P = 0.001).
• sICAM-1 levels were significantly higher in active CD and UC compared to inactive disease and controls (P = 0.00002).
• CD patients had higher sICAM-1 levels (365 ng/ml) than UC patients (300 ng/ml) (P = 0.01).
• Weak but significant correlations were observed between sICAM-1 and soluble IL-2 receptors, orosomucoid, and C-reactive protein.

Conclusions:

• Elevated circulating sICAM-1 levels are indicative of active inflammation in IBD.
• Increased sICAM-1 may reflect heightened cellular adhesiveness and signaling during immune responses in vivo.
• sICAM-1 serves as a potential biomarker for disease activity in Crohn's disease and ulcerative colitis.